| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/03/2014 | CA2877874A1 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using pi3 kinase inhibitors |
| 01/03/2014 | CA2877861A1 A nutritional approach to improving athletic performance and reducing injury with l-ergothioneine and/or vitamin d2 |
| 01/03/2014 | CA2877794A1 Pharmaceutical compositions and treatment of mastitis |
| 01/03/2014 | CA2877786A1 N-[4-(quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products |
| 01/03/2014 | CA2877724A1 Racecadotril liquid compositions |
| 01/03/2014 | CA2877718A1 Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof |
| 01/03/2014 | CA2877680A1 Use of 2-methylene-19-nor-(20s)-1a,25-dihydroxyvitamin d3 to treat secondary hyperparathyroidism |
| 01/03/2014 | CA2877590A1 Angiotensin converting enzyme inhibitors for treating optic neuropathy or congenital optic atrophy |
| 01/03/2014 | CA2877589A1 Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and cns disorders |
| 01/03/2014 | CA2877536A1 Methods of using polymers |
| 01/03/2014 | CA2877514A1 Methods of reducing the risk of a cardiovascular event in a subject on statin therapy |
| 01/03/2014 | CA2877449A1 2-aminopyrazine derivatives as csf-1 r kinase inhibitors |
| 01/03/2014 | CA2877444A1 Pharmaceutical composition comprising fimasartan and hydrochlorothiazide |
| 01/03/2014 | CA2877434A1 Method of treating lymphoma using thienotriazolodiazepine compounds |
| 01/03/2014 | CA2877378A1 Methods of treating breast cancer with gemcitabine therapy |
| 01/03/2014 | CA2877326A1 Cyanoguanidines and their use as antiviral agents |
| 01/03/2014 | CA2877167A1 Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes |
| 01/03/2014 | CA2876993A1 Pyrrolidine derivatives and their use as complement pathway modulators |
| 01/03/2014 | CA2876929A1 Racecadotril lipid compositions |
| 01/03/2014 | CA2876801A1 Injectable supersaturated acetaminophen solution for spinal administration |
| 01/03/2014 | CA2876789A1 Thienopyridone derivatives useful as activators of ampk |
| 01/03/2014 | CA2876780A1 A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| 01/03/2014 | CA2876778A1 A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| 01/03/2014 | CA2876728A1 Polymer-nsaid conjugate |
| 01/03/2014 | CA2876703A1 Oxabicycloheptanes and oxabicycloheptenes for the treatment of reperfusion injury |
| 01/03/2014 | CA2876496A1 Methods for treating hcv |
| 01/03/2014 | CA2876241A1 Induction of estrogen receptor beta by cholesterol biosynthesis inhibitors and methods of treatment of cancer |
| 01/03/2014 | CA2876240A1 Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
| 01/03/2014 | CA2876158A1 Antimicrobial compounds |
| 01/03/2014 | CA2876157A1 Antimicrobial compounds |
| 01/03/2014 | CA2875572A1 Dimethyl-benzoic acid compounds |
| 01/03/2014 | CA2875569A1 Phenoxyethyl piperidine compounds |
| 01/03/2014 | CA2875461A1 3-o-heteroaryl-ingenol |
| 01/02/2014 | US20140005617 Fentanyl transdermal patch |
| 01/02/2014 | US20140005412 TREATMENT OF ARTERIAL AGEING BY HMG CoA REDUCTASE INHIBITOR |
| 01/02/2014 | US20140005402 Crystalline forms of pitavastatin calcium |
| 01/02/2014 | US20140005379 Nanoparticle delivery system and components thereof |
| 01/02/2014 | US20140005371 Caprazene as a novel compound and derivatives thereof, and caprazol as a novel compound and derivatives thereof |
| 01/02/2014 | US20140005274 Aqueous ophthalmic composition |
| 01/02/2014 | US20140005272 Administration of n,n-dimethylacetamide and its monomethylated metabolites for the treatment of inflammatory disorders |
| 01/02/2014 | US20140005271 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES OR INFECTIOUS DISEASES, CONTAINING m-3M3FBS, WHICH IS ACTIVATOR OF PHOSPHOLIPASE C, AS ACTIVE INGREDIENT |
| 01/02/2014 | US20140005270 Dietary and pharmaceutical compositions containing tricyclic diterpenes and their derivatives and their uses |
| 01/02/2014 | US20140005269 Polymeric matrix of polymer-lipid nanoparticles as a pharmaceutical dosage form |
| 01/02/2014 | US20140005268 Pharmaceutical composition for treating oxidative stress-induced pathology and use thereof |
| 01/02/2014 | US20140005267 Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated epa and dha |
| 01/02/2014 | US20140005266 Topical formulations for administration of omega-3 fatty acids |
| 01/02/2014 | US20140005265 Methods for treating hypertriglyceridemia |
| 01/02/2014 | US20140005264 Methods of treating pediatric metabolic syndrome |
| 01/02/2014 | US20140005262 Racecadotril lipid compostions |
| 01/02/2014 | US20140005261 Racecadotril liquid compositions |
| 01/02/2014 | US20140005260 Method for inhibiting cancer metastasis by amiodarone |
| 01/02/2014 | US20140005259 Microbicidal and antiparasitic compositions |
| 01/02/2014 | US20140005258 Delivery of Therapeutic Agents Using Oligonucleotide-Modified Nanoparticles as Carriers |
| 01/02/2014 | US20140005256 Formulations with anti-tumour action |
| 01/02/2014 | US20140005255 Agonists Of Toll Like Receptor For Treating Cardiovasuclar Disease And Obesity |
| 01/02/2014 | US20140005253 Compositions and methods for treating lung disease and injury |
| 01/02/2014 | US20140005250 Compositions and Methods for Increasing Drug Efficacy in Cancer |
| 01/02/2014 | US20140005244 Family of polyamine arylethylamide compounds, and their cosmetic or dermocosmetic use |
| 01/02/2014 | US20140005243 Methods of treating pediatric patients using dexmedetomidine |
| 01/02/2014 | US20140005242 Allantoin-Containing Skin Cream |
| 01/02/2014 | US20140005238 Methods for enhancing exercise performance |
| 01/02/2014 | US20140005236 Method of inhibiting harmful microorganisms and barrier-forming composition therefor |
| 01/02/2014 | US20140005233 Pharmaceutical compositions and methods for producing low impurity concentrations of the same |
| 01/02/2014 | US20140005226 Phenoxyethyl piperidine compounds |
| 01/02/2014 | US20140005225 Method of inhibiting c-kit kinase |
| 01/02/2014 | US20140005223 Alfentanil composition for the treatment of acute pain |
| 01/02/2014 | US20140005220 Beta carboline derivatives useful in the treatment of proliferative disorders |
| 01/02/2014 | US20140005219 Intrathecal hydromorphone solutions having improved stability |
| 01/02/2014 | US20140005218 Sublingual and buccal film compositions |
| 01/02/2014 | US20140005217 Nalmefene for reduction of alcohol consumption in specific target populations |
| 01/02/2014 | US20140005216 Nalmefene for reduction of alcohol consumption in specific target populations |
| 01/02/2014 | US20140005215 Selective Opioid Compounds |
| 01/02/2014 | US20140005211 Derivatives of pyrazole-substituted amino-heteroaryl compounds |
| 01/02/2014 | US20140005207 Saspase-flg2 complex, modulating agents, and uses |
| 01/02/2014 | US20140005205 Itraconazole compositions and dosage forms, and methods of using the same |
| 01/02/2014 | US20140005204 Itraconazole compositions with improved bioavailability |
| 01/02/2014 | US20140005203 Treatment of Vasomotor Symptoms |
| 01/02/2014 | US20140005202 Inhibitors of Phosphodiesterase Type 5A for Treating or Preventing Muscle Disease or the Symptoms Thereof in a Patient |
| 01/02/2014 | US20140005199 Implant for the controlled release of pharmaceutically active agents |
| 01/02/2014 | US20140005196 Method of inhibiting apolipoprotein-e expression comprising administering a triarylmethyl amine compound |
| 01/02/2014 | US20140005192 Inhibitors of influenza viruses replication |
| 01/02/2014 | US20140005187 Oxidosqualene cyclase as a protein target for anticancer therapeutics |
| 01/02/2014 | US20140005185 Novel imidazo-oxazine compound or salt thereof |
| 01/02/2014 | US20140005179 Oral pharmaceutical dispersion compositions |
| 01/02/2014 | US20140005178 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 01/02/2014 | US20140005177 Pyridinyl- and pyrazinyl-methyloxy-aryl derivatives useful as inhibitors of spleen tyrosine kinase (syk) |
| 01/02/2014 | US20140005176 2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders |
| 01/02/2014 | US20140005173 Compositions and Methods for the Treatment of Catatonia |
| 01/02/2014 | US20140005171 Ophthalmic Ointment Composition Comprising a Drug, an Ointment Base and a Solubilizing/Dispersing Agent |
| 01/02/2014 | US20140005168 5-azaindazole compounds and methods of use |
| 01/02/2014 | US20140005160 Method for Treating Refractory Cancer |
| 01/02/2014 | US20140005158 Use of mifepristone for the treatment of amyotrophic lateral sclerosis |
| 01/02/2014 | US20140005157 Treatment of uterine fibroids by intravaginal administration of a low dose of selective progesterone receptor modulator (sprm), anti-progestin, or anti-progestational |
| 01/02/2014 | US20140005156 Aminoalkylsterol compounds with antitumoral and neuroprotective activity |
| 01/02/2014 | US20140005155 Organic compounds |
| 01/02/2014 | US20140005154 6,7-Dihydrothieno[3,2-d]pyrimidine for the Treatment of Inflammatory Diseases |
| 01/02/2014 | US20140005152 Use of 2-Methylene-19-Nor-(20S)-1alpha,25-Dihydroxyvitamin D3 to Treat Secondary Hyperparathyroidism |
| 01/02/2014 | US20140005151 Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof |
| 01/02/2014 | US20140005150 3,4-diarylpyrazoles as protein kinase inhibitors |
| 01/02/2014 | US20140005148 Stable liquid formulations of nitrogen mustards |